Non Physically Dependent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PRA Health Sciences selected for the study which will position Awakn at the Forefront of Psychedelic Research for Addiction Treatment
PRA Health Sciences selected for the study which will position Awakn at the Forefront of Psychedelic Research for Addiction Treatment
Awakn Life Sciences announced today the selection of contract research organization (‘CRO’), PRA Health Sciences (NASDAQ: PRAH), to conduct a Phase IIb trial studying the effectiveness of MDMA-Assisted Psychotherapy as a treatment for patients with Non-Physically Dependent (‘Harmful Use’) Alcohol Use Disorder (“AUD”).
Awakn’s Phase IIb study will take place in the United Kingdom and will be a double-blind, placebo-controlled clinical trial designed to investigate the safety and efficacy of MDMA as a pharmacological treatment for Alcohol Use Disorder. ....

United States , United Kingdom , City Of , Tim Regan , Valter Pinto , Edmundj Safra , Ben Sessa , David Nutt , Anthony Tennyson , Awakn Life Sciences , Health Sciences Contact , Forefront Of Psychedelic Research For Addiction Treatment , Drug Administration , Strategic Communications , Heath Sciences , Imperial College London , Pra Health Sciences , Division Of Brain Science , Health Sciences , Psychedelic Research , Life Sciences , Non Physically Dependent , Harmful Use , Alcohol Use Disorder , Alcohol Use , Chief Medical Officer ,